December 4, 2025Pharmacognosy MagazineOpen Access

Critical Review of 1-Deoxynojirimycin (DNJ)  in Mulberry in Curing Diabetes Mellitus

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Critical review highlights therapeutic potential of 1-deoxynojirimycin in diabetes management, suggesting benefits of mulberry leaf extracts.

1-deoxynojirimycin significantly reduces insulin resistance and modulates diabetes mellitus symptoms.
Bioavailability studies emphasize the need for innovative formulation techniques to improve therapeutic outcomes.
Assessment of α-glucosidase inhibitory effects suggests enhanced carbohydrate digestion control in diabetes therapy.
Natural compounds like mulberry provide a promising pathway for sustainable diabetes management.

M Sivaprakash (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Critical review highlights therapeutic potential of 1-deoxynojirimycin in diabetes management, suggesting benefits of mulberry leaf extracts.